Quick Answer
MEDICINOVA INC reported R&D Expense of $5.01 million for fiscal year 2012.
MEDICINOVA INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2012 | $5.01M | -35.6% |
| 2011 | $7.78M | -19.8% |
| 2010 | $9.71M | -10.7% |
| 2009 | $10.87M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2013 | $785.6K | -10.0% | -17.0% |
| June 30, 2013 | $946.1K | -36.2% | +35.9% |
| March 31, 2013 | $696.0K | -62.9% | -20.2% |
| September 30, 2012 | $872.6K | -48.1% | -41.2% |
| June 30, 2012 | $1.48M | -27.3% | -21.0% |
| March 31, 2012 | $1.88M | -28.4% | +11.8% |
| September 30, 2011 | $1.68M | -22.8% | -17.7% |
| June 30, 2011 | $2.04M | -11.5% | -22.3% |
- MEDICINOVA INC showed a decrease of -35.6% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2012 period, MEDICINOVA INC’s r&d expense has declined by 53.9% (from $10.87 million to $5.01 million).
- The most recent figure is from MEDICINOVA INC’s fiscal year 2012 report (Form 10-K), filed with the SEC on March 28, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: